Physician profile
David Beckner
NPI 1326074220
$7,457.39
in general payments reported to CMS, 2019-2025
42 companies · $1,030 in 2025
The $1,030 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $667 · 2021: $831 · 2022: $1,308 · 2023: $1,160 · 2024: $1,887 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,076.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,673.65 | 2020-2025 | Xience Skypoint, Ultreon, Coroflow |
| Novartis Pharmaceuticals Corporation | $1,631.70 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $498.71 | 2019-2023 | Lifevest |
| Irhythm Technologies, INC. | $394.63 | 2024 | Zio Monitor, Zio Xt Patch |
| Abiomed | $371.36 | 2019-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $343.61 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $305.04 | 2019-2024 | Brilinta, Wainua |
| Amgen INC. | $271.50 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.35 | 2019-2024 | Jardiance |
| Esperion Therapeutics, INC. | $180.47 | 2022-2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $153.49 | 2019-2024 | Xarelto |
| Penumbra, INC. | $149.25 | 2025 | Indigo System |
| Pfizer INC. | $140.64 | 2019-2024 | |
| Medtronic, INC. | $136.18 | 2022-2023 | Telescope, Azure Xt Dr Mri Surescan |
| Cardiovascular Systems INC. | $103.67 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Beckner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.